Literature DB >> 19178534

Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.

Stella Yi1, Elizabeth Selvin, Sabine Rohrmann, Shehzad Basaria, Andy Menke, Nader Rifai, Eliseo Guallar, Elizabeth A Platz, Brad Astor.   

Abstract

CONTEXT: Sex steroid hormones may play a role in the pathogenesis of chronic kidney disease (CKD).
OBJECTIVE: To determine whether sex steroid hormone concentrations are associated with kidney function or kidney damage in men in the general US population. We hypothesized that lower serum testosterone and E(2) concentrations are associated with CKD. DESIGN PATIENTS AND MEASUREMENTS: Serum sex steroid hormones were measured by electrochemiluminescence immunoassays for 1470 men who attended the morning session of Phase I of the Third National Health and Nutrition Examination Survey (NHANES III). We used two measures of CKD, estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m(2) calculated using serum creatinine or cystatin C levels and the abbreviated Modification of Diet in Renal Disease Study formulae and urinary albumin : creatinine ratio (UACR) >or= 17 mg/g.
RESULTS: Mean free testosterone concentration was higher in men with an eGFR < 60 ml/min/1.73 m(2) than in men with a higher eGFR. In multivariable adjusted models, the odds of an eGFR < 60 ml/min/1.73 m(2) or UACR >/= 17 mg/g did not differ across tertiles of hormones with the exception of free E(2); those in the highest vs. lowest tertile had an elevated odds of decreased eGFR (OR: 3.04, 95% CI (1.22, 7.57); P-trend = 0.02).
CONCLUSIONS: In a nationally representative sample of US adult men, higher free E(2) concentration was significantly associated with an eGFR < 60 ml/min/1.73 m(2) as assessed by serum creatinine or cystatin C even after multivariable adjustment. These findings are in contrast to the hypothesis that oestrogens may protect against CKD, though reverse causation cannot be ruled out. Longitudinal investigation of the role of oestrogens in kidney haemodynamics, function, and pathophysiology is warranted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19178534      PMCID: PMC2740644          DOI: 10.1111/j.1365-2265.2008.03455.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  37 in total

Review 1.  Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms.

Authors:  R K Dubey; E K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2001-03

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Testosterone making an entry into the cardiometabolic world.

Authors:  Shehzad Basaria; Adrian S Dobs
Journal:  Circulation       Date:  2007-12-04       Impact factor: 29.690

Review 4.  The role of gender in the progression of renal disease.

Authors:  Sharon R Silbiger; Joel Neugarten
Journal:  Adv Ren Replace Ther       Date:  2003-01

5.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

6.  Role of androgens in mediating renal injury in aging SHR.

Authors:  Lourdes A Fortepiani; Licy Yanes; Huimin Zhang; Lorraine C Racusen; Jane F Reckelhoff
Journal:  Hypertension       Date:  2003-10-20       Impact factor: 10.190

7.  Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans.

Authors:  Sabine Rohrmann; William G Nelson; Nader Rifai; Terry R Brown; Adrian Dobs; Norma Kanarek; James D Yager; Elizabeth A Platz
Journal:  J Clin Endocrinol Metab       Date:  2007-04-24       Impact factor: 5.958

8.  The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.

Authors:  Tazeen H Jafar; Christopher H Schmid; Paul C Stark; Robert Toto; Giuseppe Remuzzi; Piero Ruggenenti; Carmelita Marcantoni; Gavin Becker; Shahnaz Shahinfar; Paul E De Jong; Dick De Zeeuw; Anne-Lise Kamper; Svend Strangaard; Andrew S Levey
Journal:  Nephrol Dial Transplant       Date:  2003-10       Impact factor: 5.992

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Hypertension       Date:  2003-11       Impact factor: 10.190

Review 10.  Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease.

Authors:  Andrew D Rule
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-05       Impact factor: 2.894

View more
  10 in total

1.  Sex Hormones and Measures of Kidney Function in the Diabetes Prevention Program Outcomes Study.

Authors:  Catherine Kim; Ana C Ricardo; Edward J Boyko; Costas A Christophi; Marinella Temprosa; Karol E Watson; Xavier Pi-Sunyer; Rita R Kalyani
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

2.  Relationship between serum cystatin C and hypertension among US adults without clinically recognized chronic kidney disease.

Authors:  Anoop Shankar; Srinivas Teppala
Journal:  J Am Soc Hypertens       Date:  2011-04-17

3.  Association between sex steroid hormones and hematocrit in a nationally representative sample of men.

Authors:  Channing J Paller; Meredith S Shiels; Sabine Rohrmann; Andy Menke; Nader Rifai; William G Nelson; Elizabeth A Platz; Adrian S Dobs
Journal:  J Androl       Date:  2012-05-17

4.  Association of serum inorganic phosphate with sex steroid hormones and vitamin D in a nationally representative sample of men.

Authors:  W Wulaningsih; M Van Hemelrijck; K Michaelsson; N Kanarek; W G Nelson; J H Ix; E A Platz; S Rohrmann
Journal:  Andrology       Date:  2014-10-01       Impact factor: 3.842

5.  Rapid recovery of hypogonadism in male patients with end stage renal disease after renal transplantation.

Authors:  W Reinhardt; H Kübber; S Dolff; S Benson; D Führer; S Tan
Journal:  Endocrine       Date:  2018-02-01       Impact factor: 3.633

6.  Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney.

Authors:  Qin Xu; Anjali Prabhu; Shujing Xu; Michaele B Manigrasso; Christine Maric
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-03

7.  Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.

Authors:  Alison M Mondul; Elizabeth Selvin; Angelo M De Marzo; Stephen J Freedland; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2010-01-14       Impact factor: 2.506

8.  Cross-sectional associations between healthy eating index and sex steroid hormones in men-National Health and Nutrition Examination Survey 1999-2002.

Authors:  Z Chen; G Pestoni; K A McGlynn; E A Platz; S Rohrmann
Journal:  Andrology       Date:  2019-07-10       Impact factor: 4.456

Review 9.  Male Sexual Dysfunction and Chronic Kidney Disease.

Authors:  Matthew M Edey
Journal:  Front Med (Lausanne)       Date:  2017-03-22

10.  Testosterone and gonadotropins but not SHBG vary with CKD stages in young and middle aged men.

Authors:  Britta Hylander; Mikael Lehtihet
Journal:  Basic Clin Androl       Date:  2015-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.